GLYCONSULT ApS: Financial statements 2020
CVR: 40001867
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
GLYCONSULT ApS (CVR 40001867) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -34,375 and a net result of DKK -613,034. Equity in the 2020 report amounted to DKK 40,148. The solvency ratio was 66.9%.
- Gross Profit
- DKK -34,375
- Profit/Loss
- DKK -613,034
- Equity
- DKK 40,148
- Total Assets
- DKK 60,001
Official annual report
How creditworthy is GLYCONSULT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 11, 2020, Lars Skanvig Bramhelft is registered as liquidator of GLYCONSULT ApS.
On December 11, 2020, GLYCONSULT ApS entered liquidation.
As of October 26, 2020, Casper Hempel has stepped down as adm. dir. of GLYCONSULT ApS.
About GLYCONSULT ApS
GLYCONSULT ApS was a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2018. The company has been dissolved on 1 February 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named GLYCONSULT IVS. In 2020, the company reported a gross profit of DKK -34,375 and a net result of DKK -613,034. Equity in the 2020 report amounted to DKK 40,148.